Evidence map›Paper›PMID 31193570›Full record

ArticleRadiology case reports2019

A case of a rosette-forming glioneuronal tumor arising from the pons with disappearance of contrast enhancement.

Fumine Tanaka, Megumi Matsukawa, Ryota Kogue, Maki Umino, Masayuki Maeda, Katsunori Uchida, Hiroshi Imai, Toshio Matsubara, Hajime Sakuma

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Radiology case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Pediatric rosette-forming glioneuronal tumor of the septum pellucidum.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2020
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Fumine TanakaDepartment of Radiology, Mie University School of Medicine, Mie, Japan.
Megumi MatsukawaDepartment of Radiology, Mie University School of Medicine, Mie, Japan.
Ryota KogueDepartment of Radiology, Mie University School of Medicine, Mie, Japan.
Maki UminoDepartment of Radiology, Mie University School of Medicine, Mie, Japan.
Masayuki MaedaDepartment of Advanced Diagnostic Imaging, Mie University School of Medicine, Mie, Japan.
Katsunori UchidaDepartment of Pathology, Mie University School of Medicine, Mie, Japan.
Hiroshi ImaiDepartment of Pathology, Mie University School of Medicine, Mie, Japan.
Toshio MatsubaraDepartment of Neurosurgery, Mie University School of Medicine, Mie, Japan.
Hajime SakumaDepartment of Radiology, Mie University School of Medicine, Mie, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A rosette-forming glioneuronal tumor (RGNT) is a rare and slow-growing central nervous system tumor. This tumor is usually assessed by MRI during the follow-up period. RGNT can show alteration of contrast enhancement regardless of tumor growth. Here, we report a case of RGNT arising from pons which shows partial enhancement on initial MRI, smaller enhancement on follow-up MRI at 10 months, and totally disappeared at 18 months without any therapy.

Indexed as

Contrast enhancementMRIRosette-forming glioneuronal tumor

Identifiers

PMID31193570
PMCPMC6535692

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.